Guillou P J, Giles G R, Ramsden C W
J Clin Immunol. 1986 Sep;6(5):373-80. doi: 10.1007/BF00915376.
Natural killer (NK) activity, interferon (IFN)-alpha production, and interleukin-2 (IL-2) production were measured in renal transplant recipients undergoing immunosuppression with either azathioprine and steroids (Az + P) or cyclosporine (CyA). Overall, both IFN-alpha production and IL-2 production were impaired in these two groups compared with identical studies in healthy individuals. However, on the basis of control data these two patient groups were divided into those with "normal" NK activity and those with "low" NK activity. In the CyA group those with a low NK reaction produced less IL-2 and IFN-alpha than those with normal NK activity. No such relationship between cytokine production and NK activity was discerned in the Az + P group. These data conflict with in vitro studies, which have failed to demonstrate any effect of CyA on IFN-alpha production. In addition, they suggest that whereas cyclosporine influences NK activity in vivo by inhibiting cytokine production, other factors may play a role in impairing NK activity in conventionally immunosuppressed patients.
对接受硫唑嘌呤和类固醇(Az + P)或环孢素(CyA)免疫抑制治疗的肾移植受者,检测其自然杀伤(NK)活性、α干扰素(IFN-α)产生量和白细胞介素-2(IL-2)产生量。总体而言,与对健康个体进行的相同研究相比,这两组患者的IFN-α产生量和IL-2产生量均受损。然而,根据对照数据,这两组患者被分为NK活性“正常”组和NK活性“低”组。在CyA组中,NK反应低的患者产生的IL-2和IFN-α比NK活性正常的患者少。在Az + P组中,未发现细胞因子产生与NK活性之间存在此类关系。这些数据与体外研究结果相矛盾,体外研究未能证明CyA对IFN-α产生有任何影响。此外,这些数据表明,虽然环孢素通过抑制细胞因子产生在体内影响NK活性,但其他因素可能在传统免疫抑制患者的NK活性受损中起作用。